• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间充质干细胞的心脏分化:生物和化学诱导剂的影响。

Cardiac Differentiation of Mesenchymal Stem Cells: Impact of Biological and Chemical Inducers.

机构信息

School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, 632014, India.

Stem Cell and Molecular Biology Lab, Bhupat and Jyoti Mehta School of Biosciences, Department of Biotechnology, Indian Institute of Technology Madras, Chennai, 600036, India.

出版信息

Stem Cell Rev Rep. 2021 Aug;17(4):1343-1361. doi: 10.1007/s12015-021-10165-3. Epub 2021 Apr 16.

DOI:10.1007/s12015-021-10165-3
PMID:33864233
Abstract

Cardiovascular disorders (CVDs) are the leading cause of global death, widely occurs due to irreparable loss of the functional cardiomyocytes. Stem cell-based therapeutic approaches, particularly the use of Mesenchymal Stem Cells (MSCs) is an emerging strategy to regenerate myocardium and thereby improving the cardiac function after myocardial infarction (MI). Most of the current approaches often employ the use of various biological and chemical factors as cues to trigger and modulate the differentiation of MSCs into the cardiac lineage. However, the recent advanced methods of using specific epigenetic modifiers and exosomes to manipulate the epigenome and molecular pathways of MSCs to modify the cardiac gene expression yield better profiled cardiomyocyte like cells in vitro. Hitherto, the role of cardiac specific inducers triggering cardiac differentiation at the cellular and molecular level is not well understood. Therefore, the current review highlights the impact and recent trends in employing biological and chemical inducers on cardiac differentiation of MSCs. Thereby, deciphering the interactions between the cellular microenvironment and the cardiac inducers will help us to understand cardiomyogenesis of MSCs. Additionally, the review also provides an insight on skeptical roles of the cell free biological factors and extracellular scaffold assisted mode for manipulation of native and transplanted stem cells towards translational cardiac research.

摘要

心血管疾病(CVDs)是全球死亡的主要原因,广泛发生是由于功能性心肌细胞的不可挽回的损失。基于干细胞的治疗方法,特别是间充质干细胞(MSCs)的使用,是一种新兴的策略,可用于再生心肌,从而改善心肌梗死后的心脏功能。目前大多数方法通常采用各种生物和化学因子作为线索来触发和调节 MSC 向心脏谱系的分化。然而,最近使用特定表观遗传修饰剂和外泌体的先进方法来操纵 MSC 的表观基因组和分子途径,以修饰心脏基因表达,从而在体外产生更好的心肌样细胞。迄今为止,细胞和分子水平上触发心脏分化的心脏特异性诱导物的作用尚不清楚。因此,本综述强调了生物和化学诱导物在 MSC 心脏分化中的作用和最新趋势。从而,解析细胞微环境与心脏诱导物之间的相互作用将有助于我们理解 MSC 的心肌发生。此外,该综述还提供了对无细胞生物因子和细胞外支架辅助模式的质疑作用的见解,用于操纵天然和移植干细胞,以促进转化心脏研究。

相似文献

1
Cardiac Differentiation of Mesenchymal Stem Cells: Impact of Biological and Chemical Inducers.间充质干细胞的心脏分化:生物和化学诱导剂的影响。
Stem Cell Rev Rep. 2021 Aug;17(4):1343-1361. doi: 10.1007/s12015-021-10165-3. Epub 2021 Apr 16.
2
Nesprin-1 has key roles in the process of mesenchymal stem cell differentiation into cardiomyocyte-like cells in vivo and in vitro.Nesprin-1在体内和体外间充质干细胞分化为心肌样细胞的过程中发挥关键作用。
Mol Med Rep. 2015 Jan;11(1):133-42. doi: 10.3892/mmr.2014.2754. Epub 2014 Oct 23.
3
Small molecule 2'-deoxycytidine differentiates human umbilical cord-derived MSCs into cardiac progenitors in vitro and their in vivo xeno-transplantation improves cardiac function.小分子 2'-脱氧胞苷在体外将人脐带间充质干细胞分化为心脏祖细胞,其异种移植在体内改善心脏功能。
Mol Cell Biochem. 2020 Jul;470(1-2):99-113. doi: 10.1007/s11010-020-03750-6. Epub 2020 May 15.
4
Exosomes derived from adipose tissue, bone marrow, and umbilical cord blood for cardioprotection after myocardial infarction.脂肪组织、骨髓和脐血来源的外泌体在心肌梗死后的心脏保护作用。
J Cell Biochem. 2020 Mar;121(3):2089-2102. doi: 10.1002/jcb.27399. Epub 2019 Nov 17.
5
Impact of myocardial infarct proteins and oscillating pressure on the differentiation of mesenchymal stem cells: effect of acute myocardial infarction on stem cell differentiation.心肌梗死蛋白和振荡压力对间充质干细胞分化的影响:急性心肌梗死对干细胞分化的作用
Stem Cells. 2008 Jul;26(7):1901-12. doi: 10.1634/stemcells.2007-0708. Epub 2008 Apr 10.
6
Paracrine Mechanisms Involved in Mesenchymal Stem Cell Differentiation into Cardiomyocytes.间充质干细胞分化为心肌细胞所涉及的旁分泌机制。
Curr Stem Cell Res Ther. 2019;14(1):9-13. doi: 10.2174/1574888X13666180821160421.
7
Role of interleukin-7 in fusion of rat bone marrow mesenchymal stem cells with cardiomyocytes in vitro and improvement of cardiac function in vivo.白细胞介素-7 在大鼠骨髓间充质干细胞与心肌细胞体外融合及改善体内心功能中的作用。
Cardiovasc Ther. 2018 Dec;36(6):e12479. doi: 10.1111/1755-5922.12479. Epub 2018 Dec 6.
8
Preinduction with bone morphogenetic protein-2 enhances cardiomyogenic differentiation of c-kit mesenchymal stem cells and repair of infarcted myocardium.骨形态发生蛋白-2 的诱导前处理增强了 c-kit 间充质干细胞的心肌生成分化能力和梗死心肌的修复作用。
Int J Cardiol. 2018 Aug 15;265:173-180. doi: 10.1016/j.ijcard.2018.01.134.
9
Mechanistic effects of mesenchymal and hematopoietic stem cells: New therapeutic targets in myocardial infarction.间充质和造血干细胞的作用机制:心肌梗死的新治疗靶点。
J Cell Biochem. 2018 Jul;119(7):5274-5286. doi: 10.1002/jcb.26637. Epub 2018 Mar 12.
10
The harsh microenvironment in infarcted heart accelerates transplanted bone marrow mesenchymal stem cells injury: the role of injured cardiomyocytes-derived exosomes.梗死心脏恶劣的微环境加速移植骨髓间充质干细胞损伤:损伤心肌细胞衍生的外泌体的作用。
Cell Death Dis. 2018 Mar 2;9(3):357. doi: 10.1038/s41419-018-0392-5.

引用本文的文献

1
Fabrication and Evaluation of Screen-Printed Electrodes on Chitosan Films for Cardiac Patch Applications with In Vitro and In Vivo Evaluation.用于心脏贴片应用的壳聚糖膜上丝网印刷电极的制备与评估:体外和体内评估
Polymers (Basel). 2025 Jul 30;17(15):2088. doi: 10.3390/polym17152088.
2
Semiquantitative Cardiac-Specific Gene Expression Validation of the DNA Methylation Microarray in Human Mesenchymal Stem Cells.人骨髓间充质干细胞中DNA甲基化微阵列的半定量心脏特异性基因表达验证
Methods Mol Biol. 2025;2880:147-158. doi: 10.1007/978-1-0716-4276-4_6.
3
Genetically modified mesenchymal stromal cells: a cell-based therapy offering more efficient repair after myocardial infarction.

本文引用的文献

1
Quest for Pan-Cancer Diagnosis/Prognosis Ends with HrC Test Measuring Oct4A in Peripheral Blood.寻求泛癌诊断/预后的研究最终以检测外周血中 Oct4A 的 HrC 测试为终点。
Stem Cell Rev Rep. 2021 Oct;17(5):1827-1839. doi: 10.1007/s12015-021-10167-1. Epub 2021 May 6.
2
Regulation of cardiomyocyte fate plasticity: a key strategy for cardiac regeneration.调控心肌细胞命运可塑性:心脏再生的关键策略。
Signal Transduct Target Ther. 2021 Jan 27;6(1):31. doi: 10.1038/s41392-020-00413-2.
3
The emerging therapeutic role of mesenchymal stem cells in anthracycline-induced cardiotoxicity.
基因修饰间充质基质细胞:一种细胞疗法,能在心肌梗死后提供更有效的修复。
Stem Cell Res Ther. 2024 Sep 27;15(1):323. doi: 10.1186/s13287-024-03942-7.
4
Optimizing Cardiomyocyte Differentiation: Comparative Analysis of Bone Marrow and Adipose-Derived Mesenchymal Stem Cells in Rats Using 5-Azacytidine and Low-Dose FGF and IGF Treatment.优化心肌细胞分化:使用5-氮杂胞苷以及低剂量成纤维细胞生长因子和胰岛素样生长因子处理对大鼠骨髓间充质干细胞和脂肪来源间充质干细胞的比较分析
Biomedicines. 2024 Aug 22;12(8):1923. doi: 10.3390/biomedicines12081923.
5
Novel biphasic mechanism of the canonical Wnt signalling component PYGO2 promotes cardiomyocyte differentiation from hUC-MSCs.新型双相机制的经典 Wnt 信号成分 PYGO2 促进人 UC-MSCs 向心肌细胞分化。
Cell Tissue Res. 2023 Jul;393(1):163-179. doi: 10.1007/s00441-023-03774-6. Epub 2023 May 26.
6
Effect of CDM3 on co-culture of human-induced pluripotent stem cells with Matrigel-covered polycaprolactone to prepare cardiac patches.CDM3 对人诱导多能干细胞与覆盖有 Matrigel 的聚己内酯共培养制备心脏补片的影响。
In Vitro Cell Dev Biol Anim. 2023 Apr;59(4):256-263. doi: 10.1007/s11626-023-00764-4. Epub 2023 Apr 17.
7
Direct Cardiac Reprogramming: Current Status and Future Prospects.直接心脏重编程:现状与未来展望。
Adv Exp Med Biol. 2023;1436:1-18. doi: 10.1007/5584_2022_760.
8
Cell-Based and Selected Cell-Free Therapies for Myocardial Infarction: How Do They Compare to the Current Treatment Options?基于细胞和无细胞的心肌梗死治疗方法:它们与当前的治疗选择相比如何?
Int J Mol Sci. 2022 Sep 7;23(18):10314. doi: 10.3390/ijms231810314.
9
SDF-1/CXCR4-Mediated Stem Cell Mobilization Involved in Cardioprotective Effects of Electroacupuncture on Mouse with Myocardial Infarction.SDF-1/CXCR4 介导的干细胞动员参与电针对心肌梗死小鼠的心脏保护作用。
Oxid Med Cell Longev. 2022 Aug 9;2022:4455183. doi: 10.1155/2022/4455183. eCollection 2022.
10
Mesenchymal Stem Cell Application and Its Therapeutic Mechanisms in Intracerebral Hemorrhage.间充质干细胞在脑出血中的应用及其治疗机制
Front Cell Neurosci. 2022 Jun 13;16:898497. doi: 10.3389/fncel.2022.898497. eCollection 2022.
间充质干细胞在蒽环类抗生素诱导的心脏毒性中的治疗作用。
Cell Tissue Res. 2021 Apr;384(1):1-12. doi: 10.1007/s00441-020-03364-w. Epub 2021 Jan 12.
4
Therapeutic approach for global myocardial injury using bone marrow-derived mesenchymal stem cells by cardiac support device in rats.应用心脏支持装置经骨髓间充质干细胞对大鼠整体心肌损伤的治疗方法。
Biomed Microdevices. 2021 Jan 8;23(1):5. doi: 10.1007/s10544-020-00538-9.
5
Exosomes Derived from Mesenchymal Stem Cells Protect the Myocardium Against Ischemia/Reperfusion Injury Through Inhibiting Pyroptosis.间充质干细胞来源的外泌体通过抑制细胞焦亡保护心肌免受缺血/再灌注损伤。
Drug Des Devel Ther. 2020 Sep 16;14:3765-3775. doi: 10.2147/DDDT.S239546. eCollection 2020.
6
Mesenchymal stromal/stem cell-derived extracellular vesicles in tissue repair: challenges and opportunities.间充质基质/干细胞来源的细胞外囊泡在组织修复中的挑战与机遇
Theranostics. 2020 May 1;10(13):5979-5997. doi: 10.7150/thno.40122. eCollection 2020.
7
Graphene-incorporated chitosan substrata for adhesion and differentiation of human mesenchymal stem cells.用于人骨髓间充质干细胞黏附与分化的石墨烯复合壳聚糖基质
J Mater Chem B. 2013 Feb 21;1(7):933-938. doi: 10.1039/c2tb00274d. Epub 2013 Jan 10.
8
Combination of HGF and IGF-1 promotes connexin 43 expression and improves ventricular arrhythmia after myocardial infarction through activating the MAPK/ERK and MAPK/p38 signaling pathways in a rat model.在大鼠模型中,肝细胞生长因子(HGF)和胰岛素样生长因子-1(IGF-1)联合通过激活丝裂原活化蛋白激酶/细胞外信号调节激酶(MAPK/ERK)和丝裂原活化蛋白激酶/p38(MAPK/p38)信号通路促进连接蛋白43表达并改善心肌梗死后的室性心律失常。
Cardiovasc Diagn Ther. 2019 Aug;9(4):346-354. doi: 10.21037/cdt.2019.07.12.
9
Global Updates on Cardiovascular Disease Mortality Trends and Attribution of Traditional Risk Factors.全球心血管疾病死亡率趋势及传统危险因素归因的最新进展
Curr Diab Rep. 2019 Jun 20;19(7):44. doi: 10.1007/s11892-019-1161-2.
10
Exosomes from mesenchymal stem/stromal cells: a new therapeutic paradigm.间充质干/基质细胞来源的外泌体:一种新的治疗模式。
Biomark Res. 2019 Apr 4;7:8. doi: 10.1186/s40364-019-0159-x. eCollection 2019.